Erectile dysfunction (ED) is still a common complication of radical prostatectomy. Current treatments of ED are mainly symptomatic. Mesenchymal stem cells (MSCs) have been widely investigated as a potential curative treatment. Although MSC therapy consistently improved erectile functions in the pre-clinical studies the initial expectations seem to be unmet.

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/Stem-Cell-Tx-of-Erectile-Dysfunction-Sept-2016.pdf” title=”Stem Cell Tx of Erectile Dysfunction Sept 2016″]